MX1 and systemic lupus erythematosus: Non-lesional skin biopsies from SLE patients (n = 3) showed the highest expression of MxA followed by non-lesional skin from At-Risk individuals (n = 3) in comparison with skin biopsies from healthy controls (Fig. 7e).